
RECELL® System
RECELL uses a small piece of the patient’s skin to create a multi-phenotype suspension of Spray-On Skin Cells.
The application of different cell types stimulates healing and regimentation throughout the wound bed as opposed to solely relying on healing from the wound edges for definitive closure.
Autologous cell therapy at the point-of-care allows for delivery of the patient’s own cells.
- Instructions for use
- Clinical Studies
Author
Title
Link
A Comparative Study of the ReCell® Device and Autologous Split-Thickness Meshed Skin Graft in the Treatment of Acute Burn Injuries
Demonstration of the safety and effectiveness of the RECELL1 System combined with split-thickness meshed autografts for the reduction of donor skin to treat mixed-depth burn injuries
Maximizing wound coverage in full-thickness skin defects: A randomized-controlled trial of autologous skin cell suspension and widely meshed autograft versus standard autografting
